SPY765.90−0.17%QQQ739.41−0.23%BTC/USD84,242.00−0.17%DIA511.90−0.15%GLD391.02−0.17%TLT79.52+0.13%
Benzinga

ORIC Pharmaceuticals Inc (ORIC) Stock Price, Quote, News & History

ORICNASDAQ
Trade with Public
Trade with Public
$13.18
-0.15-1.13%
At close: Sep 24, 5:00 PM EST
$13.18
N/A
After Hours: 4:40 PM EST
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareOptionsStock Report

ORIC Pharmaceuticals (ORIC) Stock Price, Quote, News & History | Benzinga

Key Statistics

Open
$13.22
Close
$13.18
Volume / Avg.
2.00M / 1.52M
Day Range
$12.79 - $13.51
52 Wk Range
7.23 - 14.93
Market Cap
$1.36B
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
54
Short Interest
16.86%
Days to Cover
16.16

Recent ORIC Pharmaceuticals, Inc. News

Bandwidth, Traws Pharma And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Dow futures up 400 points; Bandwidth Inc (BAND) falls after $275M offering; other stocks declining in pre-market trading.
Avi Kapoor

What's Behind The Drop In Oric Pharmaceuticals Stock Today?

Shares of Oric Pharmaceuticals, Inc. (NASDAQ: ORIC) are tumbling Wednesday after the company announced an update from the Phase 1b trial of rinzimetostat in combination with darolutamide in patients with metastatic castration-resistant prostate cancer.
Alex Perry

Beyond Meat Posts Downbeat Q4 Results, Joins RH, ORIC Pharmaceuticals And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

US stock futures higher with Dow up 200 pts, Beyond Meat shares drop after downbeat results; ORIC, RH, Aptiv, Sweetgreen, Nike, and others also decline.
Avi Kapoor

Why nCino Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket

Shares of nCino Inc (NASDAQ: NCNO) jumped 18% in pre-market trading after reporting strong Q4 results and issuing positive guidance for Q1 and FY27.
Avi Kapoor

ORIC Pharmaceuticals Stock Nosedives 25% After Hours: What Is Going On?

ORIC Pharmaceuticals stock rose after reporting positive cancer drug data and advancing to a Phase 3 trial, before falling sharply in after-hours trading.
Tanya Rawat

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-111.64M
Investing Cash Flow (TTM)
-99.66M
Financing Cash Flow (TTM)
172.92M
Free Cash Flow (TTM)
-112.26M
Capital Expenditure (TTM)
-620.00K
Net Change in Cash (TTM)
-38.38M

Analyst Trends and Forecast

2
Apr
2
May
1
Jun
1
Aug
1
Sep
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.3
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$1.11B
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
3.59
Earnings Yield % (TTM)
-9.86%
Earnings Yield % (FWD)
-14.03%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$3.68

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$37.48M
Debt to Equity
0.01
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$13.22
Close
$13.18
Volume / Avg.
2.00M / 1.52M
Day Range
$12.79 - $13.51
52 Wk Range
7.23 - 14.93
Market Cap
$1.36B
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
54
Short Interest
16.86%
Days to Cover
16.16

About

Sector
Health Care
Industry
Biotechnology
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision o...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy ORIC Pharmaceuticals (ORIC) stock?

A

You can purchase shares of ORIC Pharmaceuticals (NASDAQ:ORIC) through any online brokerage.

View our list of the best stock brokerages

Q

Who are ORIC Pharmaceuticals (ORIC) competitors?

Q

What is the forecast, or price target, for ORIC Pharmaceuticals (ORIC) stock?

A

ORIC Pharmaceuticals has a consensus price target of $20.06.

Q

What is the current price for ORIC Pharmaceuticals (ORIC)?

A

The stock price for ORIC Pharmaceuticals (NASDAQ: ORIC) is $13.18 last updated September 24, 2026 at 4:40 PM EDT.

Q

Does ORIC Pharmaceuticals (ORIC) pay a dividend?

A

There are no upcoming dividends for ORIC Pharmaceuticals.

Q

When is ORIC Pharmaceuticals (NASDAQ:ORIC) reporting earnings?

A

ORIC Pharmaceuticals does not have any upcoming earnings scheduled.

Q

Is ORIC Pharmaceuticals (ORIC) going to split?

A

There is no upcoming split for ORIC Pharmaceuticals.

Q

What sector and industry does ORIC Pharmaceuticals (ORIC) operate in?

A

ORIC Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved